Ticker Details
Sagimet Biosciences Inc. Series A
IPO Date:	July 14, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$173.01M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.28 | 4.73%
Avg Daily Range (30 D):	$0.21 | 3.53%
Avg Daily Range (90 D):	$0.22 | 3.22%

Institutional Daily Volume
Avg Daily Volume:	.77M
Avg Daily Volume (30 D):	.73M
Avg Daily Volume (90 D):	.59M

Trade Size
Avg Trade Size (Sh.):	127
Avg Trade Size (Sh.) (30 D):	91
Avg Trade Size (Sh.) (90 D):	90

Institutional Trades
Total Institutional Trades:	67
Avg Institutional Trade:	$1.3M
Avg Institutional Trade (30 D):	$2.11M
Avg Institutional Trade (90 D):	$.97M
Avg Institutional Trade Volume:	.22M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.48M
Avg Closing Trade (30 D):	$2.11M
Avg Closing Trade (90 D):	$2.11M
Avg Closing Volume:	435.26K

News

Feb 5, 2026 @ 12:00 PM Sagimet Biosciences Announces Participation in Two... Source: Na

Oct 24, 2025 @ 11:00 AM Denifanstat Achieved All Endpoints in the Treatmen... Source: Sagimet Biosciences

Sep 17, 2025 @ 11:00 AM Positive Phase 3 Results for Denifanstat for the T... Source: Sagimet Biosciences Inc.

Sep 10, 2025 @ 11:00 AM Sagimet Biosciences Announces Upcoming Presentatio... Source: Sagimet Biosciences

Aug 5, 2025 @ 11:00 AM Sagimet Biosciences to Participate in the Canaccor... Source: Sagimet Biosciences

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.4		$-.56
Diluted EPS	$-.4		$-.56
Revenue	$M		$M
Gross Profit
Net Income / Loss	$-12.91M	$-10.39M	$-18.18M
Operating Income / Loss	$-14.33M		$-19.87M
Cost of Revenue
Net Cash Flow			$M
PE Ratio